Stem cell-derived neurotrophic support for the neuromuscular junction in spinal muscular atrophy

Expert Opinion on Biological Therapy

Volumn 10, Issue 11, 2010, Pages 1587-1594

  Wyatt, Tanya J ^a   Keirstead, Hans S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylcholine receptor; Embryonic stem cells; Motor neurons; Neuromuscular junction; Neurotrophins; Spinal muscular atrophy; Subunit switching

Indexed keywords

NEUROTROPHIN;

DEGENERATIVE DISEASE; EMBRYONIC STEM CELL; HUMAN; NEUROMUSCULAR SYNAPSE; NONHUMAN; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; SPINAL MUSCULAR ATROPHY; STEM CELL TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CYCLIC AMP; EMBRYONIC STEM CELLS; HUMANS; INFANT; INFANT, NEWBORN; MICE; MICE, KNOCKOUT; MOTOR NEURONS; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEUROGENESIS; NEUROMUSCULAR JUNCTION; PLURIPOTENT STEM CELLS; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; SECOND MESSENGER SYSTEMS; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; SURVIVAL OF MOTOR NEURON 1 PROTEIN; SYNAPSES;

EID: 77958473921     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2010.529895     Document Type: Review

References (73)

1. Feldkotter M, Schwarzer V, Wirth R, et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightcycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002;70(2):10
2. Baumer D, Lee S, Nicholson G, et al. Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet 2009;5(12):e1000773
3. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80(1):10
4. Lorson CL, Rindt H, Shababi M. Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet 2010;19(R1):R111-18
5. Kariya S, Park G-H, Maeno-Hikichi Y, et al. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet 2008;17(16):2552-2569
6. Sakla M, Lorson C. Induction of full-length survival motor neuron by polyphenol botanical compounds. Hum Genet 2008;122(6):635-643
7. Monani UR, Coovert DD, Burghes AHM. Animal models of spinal muscular atrophy. Hum Mol Genet 2000;9(16):2451-2457
8. Missias AC, Chu GC, Klocke BJ, et al. Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR [gamma]-to-[epsilon] switch. Dev Biol 1996;179(1):223-238
9. Kues WA, Brenner HR, Sakmann B, Witzemann V. Local neurotrophic repression of gene transcripts encoding fetal AChRs at rat neuromuscular synapses. J Cell Biol 1995;130(4):8
10. Rossi SL, Nistor G, Wyatt T, et al. Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord. PLoS ONE 2010;5(7):e11852
11. Wu H, Xiong WC, Mei L. To build a synapse: signaling pathways in neuromuscular junction assembly. Development 2010;137:1017-1033
12. Witzemann V. Development of the neuromuscular junction. Cell Tissue Res 2006;326(2):8
13. Yumoto N, Wakatsuki S, Sehara-Fujisawa A. The acetylcholine receptor [gamma]-to-[epsilon] switch occurs in individual endplates. Biochem Biophys Res Commun 2005;331(4):1522-1527
14. Koh S, Kim KS, Choi MR, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008;1229:233-248
15. Keller-Peck CR, Walsh MK, Gan WB, et al. Asynchronous synapse elimination in neonatal motor units: studies using GFP transgenic mice. Neuron 2001;31:13
16. Balice-Gordon RJ, Lichtman JW. In vivo obsevations of pre- and postsynaptic changes during the transition from multiple to single innervation at developing neuromuscular junctions. J Neurosci 1993;13:21
17. Arnold A, Gueye M, Guettier-Sigrist S, et al. Reduced expression of nicotinic AChRs in myotubes from spinal muscular atrophy I patients. Nature 2004;84(10):7
18. Murray LM, Comley LH, Thomson D, et al. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet 2008;17(7):949-962
19. Monani UR. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 2005;48(6):885-895
20. Witzemann V, Schwarz H, Koenen M, et al. Acetylcholine receptor epsilon-subunit deletion causes muscle weakness and atrophy in juvenile and adult mice. Proc Natl Acad Sci USA 1996;93:5
21. Burghes AHBC. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci 2009;10(8):12
22. Corti S, Nizzardo M, Nardini M, et al. Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice. Brain 2010;133(2):465-481
23. Karumbayaram S, Kelly TK, Paucar AA, et al. Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Dis Model Mechanobiol 2009;2:6
24. Wada T, Honda M, Minami I, et al. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS One 2009;4(8):e6722
25. Li XJ, Du ZW, Zarnowska ED, et al. Specification of motoneurons from human embryonic stem cells. Nat Biotechnol 2005;23:6
26. Roy NS, Nakano T, Xuing L, et al. Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells. Exp Neurol 2005;196:10
27. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders, Ai time for clinical translation? J Clin Invest 2010;120(1):29-40
28. Amariglio NHA, Scheithauer BW, Cohen Y, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009;6(2):e1000029
29. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005;25(19):4694-4705
30. Deshpande DMKY, Martinez T, Carmen J, et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 2006;60(1):12
31. Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002;59(4):514-523
32. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006;441(7097):1094-1096
33. Mazzini L, Mareschi K, Ferrero I, et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 2008;265(1-2):78-83
34. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2002;181:14
35. Nayak MS, Kim YS, Goldman M, et al. Cellular therapies in motor neuron diseases. Biochim Biophys Acta 2006;1762:10
36. Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci 2006;110:6
37. Fischer LR, Glass JD. Axonal degeneration in motor neuron disease. Neurogenerative Dis 2007;4:11
38. Kong L, Wang X, Choe DW, et al. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neuroscience 2009;29(3):9
39. Gould TW, Oppenheim RW. Synaptic dysfunction in disease and following injury in the developing and adult nervous system: caveats in the choice of therapeutic intervention. Neurosci Biobehav Rev 2007;31(8):1073-1087
40. Lohof AM, Ip NY, Poo M-M. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 1993;363(6427):350-353
41. Blum R, Konnerth A. Neurotrophin-mediated rapid signaling in the central nervous system: mechanisms and functions. Physiology 2005;20(1):70-78
42. Gardiner J, Marc J. Arabidopsis thaliana, a plant model organism for the neuronal microtubule cytoskeleton? J Exp Bot 2010. [Epub ahead of print, doi: 10.1093/jxb/erq278]
43. Gao Y, Nikulina E, Mellado W, Filbin MT. Neurotrophins elevate cAMP to reach a threshold required to overcome inhibition by MAG through extracellular signal-regulated kinase-dependent inhibition of phosphodiesterase. J Neurosci 2003;23(37):7
44. Harper JMKC, Darman JS, Deshpande DM, et al. Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci USA 2004;101(18):5
45. Spencer TAF, MT. A role for cAMP in regeneration of the adult mammalian CNS. J Anat 2004;204:5
46. Briese M, Esmaeili B, Sattelle DB. Is spinal muscular atrophy the result of defects in motor neuron processes? BioEssays 2005;27(9):946-957
47. Wang T, Xie K, Lu B. Neurotrophins promote maturation of developing neuromuscular synapses. J Neurosci 1995;15(7):4796-4805
48. Lu B, Je HS. Neurotrophic regulation of the development and function of the neuromuscular synapses. J Neurocytol 2003;32:931-941
49. Grumbles RM, Sesodia S, Wood PM, Thomas CK. Neurotrophic factors improve motoneuron survival and function of muscle reinnervated by embryonic neurons. J Neuropathol Exp Neurol 2009;68(7):736-746
50. Dreyfus CF, Dai X, Lercher LD, et al. Expression of neurotrophins in the adult spinal cord in vivo. J Neurosci Res 1999;56:7
51. Riley CP, Cope TC, Buck CR. CNS neurotrophins are biologically active and expressed by multiple cell types. J Mol Histol 2004;35(8-9):771-783
52. Suzuki M, Svendsen CN. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci 2008;31(4):6
53. Brenner HR, Lomo T, Williamson R. Control of end-plate channel properties by neurotrophic effects and by muscle activity in rats. J Physiol 1987;388:367-381
54. Pinset C, Mulle C, Benoit P, et al. Functional adult acetylcholine receptor develops independently of motor innervation in Sol 8 mouse muscle cell line. EMBO J 1991;10(9):7
55. Murray LMLS, Baumer D, Parson SH, et al. Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet 2010;19(3):13
56. Greensmith L, Sieradzan K, Vrbova G. Possible consequences of disruption of neuromuscular contacts in early development for motoneurone survival. Acta Neurobiol Exp (Wars) 1993;53:319-324
57. Ebert AD, Yu J, Rose FF, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009;457(7227):277-280
58. Park I-H, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451(7175):141-146
59. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008;132(4):567-582
60. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131(5):861-872
61. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318(5858):1917-1920
62. Sendtner M. Therapy development in spinal muscular atrophy. Nat Neurosci 2010;13(7):795-799
63. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321(5893):1218-1221
64. Park I-H, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008;134(5):877-886
65. Pick M, Stelzer Y, Bar-Nur O, et al. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 2009;27(11):2686-2690
66. Marchetto MCN, Winner B, Gage FH. Pluripotent stem cells in neurodegenerative and neurodevelopmental diseses. Hum Mol Genet 2010;19(R1):5
67. Ebert AD, Svendsen CN. Stem cell model of spinal muscular atrophy. Arch Neurol 2010;67(6):665-669
68. Murray LM, Talbot K, Gillingwater TH. Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol Appl Neurobiol 2010;36(2):133-156
69. DiDonato CJ, Schmid A. Animal models of spinal muscular atrophy. J Child Neurol 2007;22:8
70. Butchbach ME, Singh J, Thorsteinsdottir M, et al. Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy. Hum Mol Genet 2010;14:15
71. Avila AM, Burnett BG, Taye AA, et al. Trichostatin A incrases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest 2007;117:12
72. Riessland M, Ackermann B, Forster B, et al. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet 2010;19:14
73. Garbes L, Riessland M, Holker I, et al. LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Hum Mol Genet 2009;18:13